Genmab | GEN - درآمد حاصل از بهره

قیمت سهام
1,751.50
تغییر روزانه
-7.00 -0.40%
ماهیانه
1.54%
سالیانه
38.08%
Q2 پیش بینی
1,668.29




درآمد حاصل از بهره تغییر دادن تاریخ
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Almirall EUR 2.71M 580K 2025-12
Amarin USD 3.37M 3.37M 2024-12
argenx SE USD 42.7M 4.3M 2025-09
AstraZeneca USD 85M 17M 2025-09
Bayer EUR 130M 38M 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Exelixis USD 15.92M 867K 2025-09
Fresenius Medical Care EUR 13.62M 5.54M 2025-12
Galapagos EUR 12.56M 4.66M 2025-03
Genmab DKK 25M 8M 2025-06
GlaxoSmithKline GBP 26M 24M 2025-09
GN Store Nord DKK 69M 52M 2025-06
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
Insmed USD 765K 55K 2024-09
Merck EUR 27M 10M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09